Usefulness of F-18 FDG-PET in detection of multiple endocrine tumors with duodenal carcinoid

Computerized Medical Imaging and Graphics

Volumn 31, Issue 3, 2007, Pages 191-194

  Hayasaka, Kazumasa ^a   Nihashi, Takashi ^a   Matsuura, Toshihiro ^a   Itoh, Kengo ^a   Tokuda, Haruhiko ^a  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Carcinoid; F 18 FDG PET; MEN

Indexed keywords

BIOPSY; BLOOD; DIAGNOSIS; DISEASES; SURGERY; TUMORS;

CARCINOID; FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY (FDG-PET);

BIOMEDICAL ENGINEERING;

FLUORODEOXYGLUCOSE F 18;

AGED; ARTICLE; BIOPSY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DUODENUM; DUODENUM CANCER; FEMALE; HUMAN; HYPERCALCEMIA; HYPERMETABOLISM; LABORATORY TEST; MULTIPLE ENDOCRINE NEOPLASIA; NUCLEAR MAGNETIC RESONANCE; PANCREAS; PANCREAS CANCER; PANCREATIC GASTRINOMA; PARATHYROID ADENOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THYROID GLAND;

AGED; DUODENAL NEOPLASMS; ENDOCRINE SYSTEM; FEMALE; HUMANS; JAPAN; POSITRON-EMISSION TOMOGRAPHY; WHOLE BODY IMAGING;

EID: 33947610294     PISSN: 08956111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.compmedimag.2007.01.004     Document Type: Article

References (21)

1. Strauss L.G., and Conti P.S. The application of PET in clinical oncology. J Nucl Med 32 (1991) 623-650
2. Kostakoglu L., Agress H., and Golodsmith F.S. Clinical role of FDG PET in evaluation of cancer patients. RadioGraphics 23 (2003) 315-340
3. Rohren E.M., Turkington T.G., and Coleman R.E. Clinical applications of PET in oncology. Radiology 231 (2004) 305-331
4. Delbeke D., and Pinson C.W. Pancreatic tumors: role of imaging in the diagnosis, staging, and treatment. J Hepatobiliary Pancreat Surg 11 (2004) 4-10
5. Papos M., Takacs T., Tron L., Farkas G., Ambrus E., Szakall Jr. S., et al. The possible role of F-18 FDG positron emission tomography in the differential diagnosis of focal pancreatic lesions. Clin Nucl Med 27 (2002) 197-201
6. Nakamoto Y., Higashi T., Sakahara H., Tamaki N., Kogire M., Doi R., et al. Delayed(18)F-fluoro-2-deoxy-d-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas. Cancer 89 (2000) 2547-2554
7. Neuman D.R., Esselstyn C.B., Maclntyre W.J., Go R.T., Obuchowski N.A., Chen E.Q., et al. Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism. J Nucl Med 37 (1996) 1809-1815
8. Adams S., Baum R., Rink T., Schumm-Drager P.M., Usadel K.H., and Hor G. Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours. Eur J Nucl Med 25 (1998) 79-83
9. Sundin A., Eriksson B., Bergstrom M., Langstrom B., Oberg K., and Orlefors H. PET in the diagnosis of neuroendocrine tumors. Ann NY Acad Sci 1014 (2004) 246-257
10. Nakamoto Y., Higashi T., Sakahara H., Tamaki Y., Itoh K., Imamura M., et al. Evaluation of pancreatic islet cell tumors by fluorine-18 fluorodeoxyglucose positron emission tomography: comparison with other modalities. Clin Nucl Med 25 (2000) 115-119
11. Gooding G.A.W., and Clark O.H. Use of color Doppler imaging in the distinction between thyroid and parathyroid lesions. Am J Surg 164 (1992) 51-56
12. Krubsack A.J., Wilson S.D., Lauson T.L., et al. Prospective comparison of radionuclide, computed tomographic sonographic, and magnetic resonance localization of parathyroid tumors. Surgery 106 (1989) 639-646
13. McDermott V.G., Fernandez R.J.M., Meakem III T.J., et al. Preoperative MR imaging in hyperparathyroidism results and factors affecting parathyroid detection. AJR 166 (1996) 705-710
14. Miller D.L. Pre-operative localization and interventional treatment of parathyroid tumors: when and how?. World J Surg 15 (1991) 706-715
15. Van Hoe L., Gryspeerdt S., Marchal G., Baert A.L., and Mertens L. Helical CT for the preoperative localization of islet cell tumors of the pancreas: value of arterial and parenchymal phase images. AJR 165 (1995) 1437-1439
16. Semelka R.C., Custodio C.M., Balci N.C., and Woosley J.T. Neuroendocrine tumors of the pancreas: spectrum of appearances on MRI. J Magn Reson Imaging 11 (2000) 141-148
17. Jackson J.E. Angiography and arterial stimulation venous sampling in the localization of pancreatic neuroendocrine tumours. Best Pract Res Clin Endocrinol Metab 19 (2005) 229-239
18. Anderson M.A., Carpenter S., Thompson N.W., Nostrant T.T., Elta G.H., and Scheiman J.M. Endoscopic ultrasound is highly accurate and directs management inpatients with neuroendocrine tumors of the pancreas. Am J Gastroenterol 95 (2000) 2271-2277
19. Virgolini I., Traub-Weidinger T., and Decristoforo C. Nuclear medicine in the detection and management of pancreatic islet-cell tumor. Best Pract Res Clin Endocrinol Metab 19 (2005) 213-227
20. Hoegerle S., Altehoefer C., Ghanem N., Koehler G., Waller C.F., Scheruebl H., et al. Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors. Radiology 220 (2001) 373-380
21. Sundin A., Eriksson B., Bergstrom M., Lanstrom B., Oberg K., and Orlefors H. PET in the diagnosis of neuroendocrine tumors. Ann NY Acad Sci 1014 (2004) 246-257